Predictive Factor of Surgical Efficacy in Male Patients with Prolactinoma.
10.3881/j.issn.1000-503X.2016.04.003
- Author:
Mei-Ting CHEN
1
;
Wei LIAN
1
;
Bing XING
1
;
Yong YAO
1
;
Ming FENG
1
;
Ren-Zhi WANG
1
Author Information
1. Department of Neurosurgery,PUMC Hospital,CAMS and PUMC,Beijing 100730,China.
- Publication Type:Journal Article
- MeSH:
Humans;
Male;
Neoplasm Recurrence, Local;
Pituitary Neoplasms;
pathology;
surgery;
Postoperative Period;
Prolactin;
blood;
Prolactinoma;
pathology;
surgery;
Retrospective Studies
- From:
Acta Academiae Medicinae Sinicae
2016;38(4):383-387
- CountryChina
- Language:English
-
Abstract:
Objective To analyze the predictive factor of surgical efficacy in male patients with prolactinoma. Method The clinical data of 184 male patients with prolactinoma who had undergone surgery were retrospectively analyzed.Results Before the surgery,the serum prolactin level from 150 to 204 952 ng/ml,the tumors sized 6 to 70 mm. Macroadenoma was seen in 152 cases (82.6%) and suprasellar adenoma with visual deficitsin 75 cases (40.7%). Complete resection was achieved in 149 patients. After surgical therapy,postoperative immediate prolactin level declined in 182 patients (98.4%);57 patients (31.0%)achieved initial remission,while the disease recurred in 26 patients (45.6%).Larger tumor had significantly lower rate of complete resection (P<0.05). The recurrence rate was significantly higher in the group with higher Ki-67 index (P<0.001). The recurrence rate was significantly lower in patients with intrasellar adenoma (P<0.001).No significant relationship was found between preoperative prolactin level and complete resection (P=0.306). Conclusions Tumor size can predictthe degree of surgical resection. The prognostic factors include tumor size,preoperative growth pattern of prolactinoma,and Ki-67 index.
